PortalPublikationenVorzeitiger Abbruch randomisierter kontrollierter Studien: V...

Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt

Standard

Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt. / Kluth, L A; Rink, M; Ahyai, S A; Fisch, M; Shariat, S F; Dahm, P.

in: UROLOGE, Jahrgang 52, Nr. 8, 01.08.2013, S. 1080-3.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kluth, LA, Rink, M, Ahyai, SA, Fisch, M, Shariat, SF & Dahm, P 2013, 'Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt', UROLOGE, Jg. 52, Nr. 8, S. 1080-3. https://doi.org/10.1007/s00120-013-3144-2

APA

Kluth, L. A., Rink, M., Ahyai, S. A., Fisch, M., Shariat, S. F., & Dahm, P. (2013). Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt. UROLOGE, 52(8), 1080-3. https://doi.org/10.1007/s00120-013-3144-2

Vancouver

Kluth LA, Rink M, Ahyai SA, Fisch M, Shariat SF, Dahm P. Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt. UROLOGE. 2013 Aug 1;52(8):1080-3. https://doi.org/10.1007/s00120-013-3144-2

Bibtex

@article{c9d6459dbd5849b1b0d20d8b0c4aa969,
title = "Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt",
abstract = "Randomized controlled trials (RCTs) stopped prematurely for beneficial therapy effects are becoming increasingly more prevalent in the urological literature and often receive great attention in the public and medical media. Urologists who practice evidence-based medicine should be aware of the potential bias and the different reasons why and how early termination of RCTs can and will affect the results. This review provides insights into the challenges clinical urologists face by interpreting the results of prematurely terminated RCTs.",
keywords = "Bias (Epidemiology), Evidence-Based Medicine, Humans, Outcome Assessment (Health Care), Physicians, Randomized Controlled Trials as Topic",
author = "Kluth, {L A} and M Rink and Ahyai, {S A} and M Fisch and Shariat, {S F} and P Dahm",
year = "2013",
month = aug,
day = "1",
doi = "10.1007/s00120-013-3144-2",
language = "Deutsch",
volume = "52",
pages = "1080--3",
journal = "UROLOGE",
issn = "0340-2592",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Vorzeitiger Abbruch randomisierter kontrollierter Studien: Vorteilsbedingter Therapieeffekt

AU - Kluth, L A

AU - Rink, M

AU - Ahyai, S A

AU - Fisch, M

AU - Shariat, S F

AU - Dahm, P

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Randomized controlled trials (RCTs) stopped prematurely for beneficial therapy effects are becoming increasingly more prevalent in the urological literature and often receive great attention in the public and medical media. Urologists who practice evidence-based medicine should be aware of the potential bias and the different reasons why and how early termination of RCTs can and will affect the results. This review provides insights into the challenges clinical urologists face by interpreting the results of prematurely terminated RCTs.

AB - Randomized controlled trials (RCTs) stopped prematurely for beneficial therapy effects are becoming increasingly more prevalent in the urological literature and often receive great attention in the public and medical media. Urologists who practice evidence-based medicine should be aware of the potential bias and the different reasons why and how early termination of RCTs can and will affect the results. This review provides insights into the challenges clinical urologists face by interpreting the results of prematurely terminated RCTs.

KW - Bias (Epidemiology)

KW - Evidence-Based Medicine

KW - Humans

KW - Outcome Assessment (Health Care)

KW - Physicians

KW - Randomized Controlled Trials as Topic

U2 - 10.1007/s00120-013-3144-2

DO - 10.1007/s00120-013-3144-2

M3 - SCORING: Zeitschriftenaufsatz

C2 - 23712423

VL - 52

SP - 1080

EP - 1083

JO - UROLOGE

JF - UROLOGE

SN - 0340-2592

IS - 8

ER -